Peter A. Thompson - Director, 10%+ Owner at Corvus Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Issuer Symbol
CRVS on Nasdaq
All Insider Reports
All Insider Reports

Peter A. Thompson - trading volume in the past year for Corvus Pharmaceuticals, Inc.

Holdings reported by Peter A. Thompson for Corvus Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 8,609,091 $66,290,000 $7.70 28 Jan 2026 Indirect
Common Stock 210,000 $445,200 $2.12 28 Jan 2026 Direct
Common Warrants (right to buy) 0 27 Jun 2025 Indirect Common Stock
Stock Option (Right to Buy) 0 28 Jan 2026 Direct Common Stock

Transactions reported by Peter A. Thompson for Corvus Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.